|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1995-3-30
|
|
pubmed:abstractText |
CYP2D6 genotyping was carried out by XbaI restriction fragment length polymorphism analysis and polymerase chain reaction in 168 healthy Danish volunteers, 77 extensive metabolizers (EM) and 91 poor metabolizers (PM) of sparteine. All EM were genotyped correctly as heterozygous or homozygous for the functional (wild type) gene, D6-wt. However, the D6-wt gene was apparently also present in 11 (12%) of the PM who accordingly were incorrectly genotyped as EM. The specificity of genotyping PM thus was 100% but the sensitivity was only 88%. The most common allele was the D6-wt with an apparent frequency of 0.741 (0.026) in the Danish population and the second most common allele was the D6-B with an apparent frequency of 0.194 (0.024). The median (range) of the sparteine metabolic ratio (MR) in 47 homozygous D6-wt EM was 0.28 (0.11-4.10) and the corresponding value in heterozygous EM was 0.36 (0.11-9.10). The median difference was 0.09 (95% confidence interval: 0.02-0.16). CYP2D6 phenotyping is a promising tool in tailoring the individual dose of tricyclic antidepressants, some neuroleplics and some antiarrhythmics. However if the genotype test could be improved with regard to both sensitivity in PM and the ability to predict CYP2D6 activity in EM then it would be of even greater clinical value in therapeutic drug monitoring.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0031-6970
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
221-5
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7867674-Adolescent,
pubmed-meshheading:7867674-Adult,
pubmed-meshheading:7867674-Alleles,
pubmed-meshheading:7867674-Cytochrome P-450 CYP2D6,
pubmed-meshheading:7867674-Cytochrome P-450 Enzyme System,
pubmed-meshheading:7867674-Debrisoquin,
pubmed-meshheading:7867674-Deoxyribonucleases, Type II Site-Specific,
pubmed-meshheading:7867674-Female,
pubmed-meshheading:7867674-Genetics, Population,
pubmed-meshheading:7867674-Genotype,
pubmed-meshheading:7867674-Homozygote,
pubmed-meshheading:7867674-Humans,
pubmed-meshheading:7867674-Male,
pubmed-meshheading:7867674-Middle Aged,
pubmed-meshheading:7867674-Mixed Function Oxygenases,
pubmed-meshheading:7867674-Mutation,
pubmed-meshheading:7867674-Polymerase Chain Reaction,
pubmed-meshheading:7867674-Polymorphism, Restriction Fragment Length,
pubmed-meshheading:7867674-Sensitivity and Specificity,
pubmed-meshheading:7867674-Sparteine
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
CYP2D6 genotype determination in the Danish population.
|
|
pubmed:affiliation |
Department of Clinical Pharmacology, Odense University, Denmark.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
